Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Med Hypotheses ; 131: 109321, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31443753

ABSTRACT

Interstitial cystitis is a chronic inflammatory condition of the urinary bladder with an unclear etiology. Currently, there are no widely accepted long-term treatment options available for patients with IC, with the European Association of Urology (EAU, 2017 guidelines), American Urology Association (AUA, 2014 guidelines), and the Royal College of Obstetricians and Gynaecologists (RCOG, 2016 guidelines) all suggesting various different conservative, pharmacological, intravesical, and surgical interventions. The endocannabinoid system represents a potential target for IC treatment and management. Activation of cannabinoid receptor 2 (CBR2) with various agonists has previously been shown to reduce leukocyte differentiation and migration, in addition to inhibiting the release of pro-inflammatory cytokines at the site of inflammation. These receptors have been identified in the detrusor and sensory nerves of the urothelium in various mammalian species, including humans. We hypothesize that by inhibiting the enzymes responsible for the catabolism of endogenous cannabinoids locally, bladder concentrations of CBR2 agonists will increase, particularly 2-arachidonyl glycerol, resulting in a diminished inflammatory response.


Subject(s)
Cystitis, Interstitial/drug therapy , Enzyme Inhibitors/therapeutic use , Molecular Targeted Therapy , Monoacylglycerol Lipases/antagonists & inhibitors , Administration, Intravesical , Animals , Arachidonic Acids/metabolism , Cystitis, Interstitial/enzymology , Endocannabinoids/metabolism , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Glycerides/metabolism , Humans , Rats , Receptor, Cannabinoid, CB2/agonists , Receptor, Cannabinoid, CB2/physiology , Urinary Bladder/drug effects , Urinary Bladder/metabolism
2.
J Clin Pathol ; 71(9): 840-844, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29764932

ABSTRACT

AIMS: To identify the presence and geographical distribution of mast cell (MC) subtypes: MCT (tryptase positive-chymase negative) and MCTC (tryptase positive-chymase positive) in bladder tissue. METHODS: Bladder tissue was obtained from patients with painful bladder syndrome/interstitial cystitis (n=14) and normal histology from University Hospital Southampton tissue bank. Sequential tissue slices were immunohistochemically stained for MC subtypes using anti-MC tryptase (for MCT and MCTC) and anti-MC chymase (for MCTC). Stained sections were photographed, and positively stained MCs were quantified using ImageJ. Data were analysed using descriptive statistics and individual paired t-tests. RESULTS: There was a significant difference in the density of MCs between each layer of the disease bladder, with the greatest accumulation within the detrusor (p<0.001). There was a significant increase in MCTC subtype in the lamina (p=0.009) in painful bladder syndrome/interstitial cystitis. CONCLUSIONS: Our results suggest that mastocytosis is present within all layers of disease bladder, especially the muscle layer. The varying increase in MC subtypes in the lamina and mucosa may explain the variability in painful bladder syndrome/interstitial cystitis symptoms. A high influx of MCTC in the mucosa of individuals who also had ulceration noted within their diagnostic notes may be of the Hunner's ulcer subclassification. These findings suggest a relationship between the pathogenesis of MC subtypes and the clinical presentation of painful bladder syndrome/interstitial cystitis. A cohort study would further elucidate the diagnostic and/or therapeutic potential of MCs in patients with painful bladder syndrome/interstitial cystitis.


Subject(s)
Cystitis, Interstitial/pathology , Mast Cells/pathology , Mastocytosis/pathology , Urinary Bladder/pathology , Biomarkers/analysis , Biopsy , Chymases/analysis , Cystitis, Interstitial/enzymology , Cystitis, Interstitial/therapy , Humans , Immunohistochemistry , Mast Cells/enzymology , Mastocytosis/enzymology , Mastocytosis/therapy , Predictive Value of Tests , Prognosis , Tryptases/analysis , Urinary Bladder/enzymology
3.
Am J Physiol Regul Integr Comp Physiol ; 314(3): R353-R365, 2018 03 01.
Article in English | MEDLINE | ID: mdl-29118019

ABSTRACT

Chronic pelvic pain causes significant patient morbidity and is a challenge to clinicians. Using a murine neurogenic cystitis model that recapitulates key aspects of interstitial cystitis/bladder pain syndrome (IC), we recently showed that pseudorabies virus (PRV) induces severe pelvic allodynia in BALB/c mice relative to C57BL/6 mice. Here, we report that a quantitative trait locus (QTL) analysis of PRV-induced allodynia in F2CxB progeny identified a polymorphism on chromosome 13, rs6314295 , significantly associated with allodynia (logarithm of odds = 3.11). The nearby gene encoding acyloxyacyl hydrolase ( Aoah) was induced in the sacral spinal cord of PRV-infected mice. AOAH-deficient mice exhibited increased vesicomotor reflex in response to bladder distension, consistent with spontaneous bladder hypersensitivity, and increased pelvic allodynia in neurogenic cystitis and postbacterial chronic pain models. AOAH deficiency resulted in greater bladder pathology and tumor necrosis factor production in PRV neurogenic cystitis, markers of increased bladder mast cell activation. AOAH immunoreactivity was detectable along the bladder-brain axis, including in brain sites previously correlated with human chronic pelvic pain. Finally, AOAH-deficient mice had significantly higher levels of bladder vascular endothelial growth factor, an emerging marker of chronic pelvic pain in humans. These findings indicate that AOAH modulates pelvic pain severity, suggesting that allelic variation in Aoah influences pelvic pain in IC.


Subject(s)
Carboxylic Ester Hydrolases/metabolism , Cystitis, Interstitial/enzymology , Escherichia coli Infections/enzymology , Hyperalgesia/enzymology , Pelvic Pain/enzymology , Pseudorabies/enzymology , Urinary Bladder/innervation , Urinary Tract Infections/enzymology , Animals , Behavior, Animal , Carboxylic Ester Hydrolases/deficiency , Carboxylic Ester Hydrolases/genetics , Cystitis, Interstitial/genetics , Cystitis, Interstitial/physiopathology , Cystitis, Interstitial/psychology , Disease Models, Animal , Escherichia coli Infections/genetics , Escherichia coli Infections/physiopathology , Escherichia coli Infections/psychology , Female , Genetic Predisposition to Disease , Hyperalgesia/genetics , Hyperalgesia/physiopathology , Hyperalgesia/psychology , Male , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Pain Perception , Pain Threshold , Pelvic Pain/genetics , Pelvic Pain/physiopathology , Phenotype , Pseudorabies/genetics , Pseudorabies/physiopathology , Pseudorabies/psychology , Quantitative Trait Loci , Severity of Illness Index , Tumor Necrosis Factor-alpha/metabolism , Urinary Bladder/metabolism , Urinary Tract Infections/genetics , Urinary Tract Infections/physiopathology , Urinary Tract Infections/psychology , Vascular Endothelial Growth Factor A/metabolism
4.
Int J Urol ; 19(2): 155-62, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22142485

ABSTRACT

OBJECTIVES: Water avoidance stress is a potent psychological stressor and it is associated with visceral hyperalgesia, which shows degeneration of the urothelial layer mimicking interstitial cystitis. Cyclooxygenase-2 inhibitors have been recognized to ameliorate frequency both in clinical and experimental settings. We investigated the voiding pattern and cyclooxygenase-2 expression in a rat bladder model of water avoidance stress. METHODS: After being subjected to water avoidance stress or a sham procedure, rats underwent metabolic cage analysis and cystometrography. Real time reverse transcription polymerase chain reaction was carried out to examine cyclooxygenase-2 messenger ribonucleic acid in bladders of rats. Protein expression of cyclooxygenase-2 was analyzed with immunohistochemistry and western blotting. Furthermore, the effects of the cyclooxygenase-2 inhibitor, etodolac, were investigated by carrying out cystometrography, immunohistochemistry and western blotting. RESULTS: Metabolic cage analysis and cystometrography showed significantly shorter intervals and less volume of voiding in water avoidance stress rats. Significantly higher expression of cyclooxygenase-2 messenger ribonucleic acid was verified by reverse transcription polymerase chain reaction. Immunohistochemistry and western blotting showed significantly higher cyclooxygenase-2 protein levels in water avoidance stress bladders. Furthermore, immunohistochemistry showed high cyclooxygenase-2 expression exclusively in smooth muscle cells. All water avoidance stress-induced changes were reduced by cyclooxygenase-2 inhibitor pretreatment. CONCLUSIONS: Chronic stress might cause frequency through cyclooxygenase-2 gene upregulation in bladder smooth muscle cells. Further study of cyclooxygenase-2 in the water avoidance stress bladder might provide novel therapeutic modalities for interstitial cystitis.


Subject(s)
Cyclooxygenase 2/genetics , Cystitis, Interstitial/genetics , Dehydration/etiology , Gene Expression Regulation , RNA/genetics , Urinary Bladder/enzymology , Animals , Cyclooxygenase 2/biosynthesis , Cystitis, Interstitial/complications , Cystitis, Interstitial/enzymology , Dehydration/enzymology , Dehydration/genetics , Disease Models, Animal , Immunohistochemistry , Male , Rats , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction
5.
Caracas; s.n; jun. 2009. 226 p. ^c30 cmtab, graf. (Ift4872009574449).
Thesis in Spanish | LILACS, LIVECS | ID: biblio-1179274

ABSTRACT

El presente trabajo involucra el estudio del sistema purinérgico mediante la purinérgico mediante la purificación y la caracterización bioquimica de la ecto-enzima E-NPP3 soluble, la cual modula la activación de los receptores purinérgicos mediante la hidrólisis de los nucleótidos extracelulares. La purificación de esta enzima, expresada en la línea celular CHO-K1, requirió el empleo de diferentes columnas cromatográficas; comprobándose la pureza, mediante la determinación de la actividad enzimática, la cuantificación de las proteínas y la detección de dicha enzima. Los resultados de la caracterización de la E-NPP3 indican que presentan un ph óptimo alcalino y que su actividad depende de la la concentración de los iones calcio y magnesio: mientras que el imidazol y el DDT ejercen acciones inhibidoras sobre su actividad. La purificación de la enzima E-NPP3 soluble representa un primer paso para futuros estudios que permitan su cristalización lo cual, constituirá una herramienta en la elaboración de agonistas y antagonistas selectivos o de anticuerpos monoclonales contra dicha enzima, útiles en el diagnóstico o el tratamiento de condiciones patológicas como el cáncer de colon y la colangiocarcinoma. Adicionalmente, teniendo en cuenta que se ha demostrado la disminución de la expresión de las ecto-nucleotidasas en el uroepitelio de pacientes que padecen cistitis intersticial; el presente trabajo comprende también, el desarrollo de un modelo de órgano aislado, la vejiga urinaria del ratón, para el estudio de la secreción de ATP desde las células uroepiteliales. Dicho modelo permitió demostrar, mediante estudios electrofisiológicos y el uso de diferentes fármacos, la contriución de los receptores purinérgicos sobre la actividad eléctrica del nervio pélvico cuando la vejiga es sometida a distensión mecánica gradual; sugiriendo la importancia de estos receptores en la transducción mecanosensorial de dicho órgano y permitiendo inferir la posible interrelación con los receptores de vaniloides en la detección de los estímulos sensoriales por parte del uroepitelio


Subject(s)
Animals , Mice , Pyrophosphatases/metabolism , Urinary Bladder/cytology , Adenosine Triphosphate/metabolism , Receptors, Purinergic/metabolism , Phosphoric Diester Hydrolases/metabolism , Epithelial Cells/metabolism , Pyrophosphatases/chemistry , Cell Line , Receptors, Purinergic/chemistry , Cholangiocarcinoma/diagnosis , Phosphoric Diester Hydrolases/chemistry , Cystitis, Interstitial/enzymology , Models, Animal , DDT/adverse effects
6.
Scand J Urol Nephrol ; 42(5): 455-61, 2008.
Article in English | MEDLINE | ID: mdl-18609268

ABSTRACT

OBJECTIVE: To identify proteins associated with interstitial cystitis (IC), protein profiles were analyzed using a proteomics-based approach. The study tested whether neutrophil elastase in urine correlates with the symptomatic condition of IC. MATERIAL AND METHODS: Proteins in urine from IC patients and healthy subjects were analyzed through a comparative proteomics approach using two-dimensional difference in-gel electrophoresis and nano-liquid chromatography-tandem mass spectrometry. Neutrophil elastase activity was measured by the digestion of peptide substrate. RESULTS: The urinary neutrophil elastase concentration was significantly higher in IC patients with pain than in healthy subjects. It was significantly increased in patients with small bladder capacity (median 6.31 ng/ml in IC with a bladder capacity < 200 ml vs 1.15 ng/ml in IC with a bladder capacity > or = 200 ml and 0.18 ng/ml in healthy bladders, p < 0.01). The concentration of neutrophil elastase did not correlate with the neutrophil count in the urine of IC patients. CONCLUSION: The concentration of neutrophil elastase increased in the urine of the IC patient subset with bladder pain and small bladder capacity.


Subject(s)
Cystitis, Interstitial/enzymology , Leukocyte Elastase/urine , Adult , Aged , Aged, 80 and over , Cystitis, Interstitial/diagnosis , Electrophoresis, Gel, Two-Dimensional , Female , Humans , Male , Mass Spectrometry , Middle Aged , Pelvic Pain/enzymology , Proteomics , Reference Values , Urodynamics/physiology
7.
J Urol ; 180(2): 737-41, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18554637

ABSTRACT

PURPOSE: Interstitial cystitis is a chronic inflammatory disease of the bladder and luminal nitric oxide has been shown to be increased in the bladder in patients with interstitial cystitis. We analyzed endogenous nitric oxide formation and inducible nitric oxide synthase gene expression in the bladder of patients with interstitial cystitis to obtain further knowledge of the localization of inducible nitric oxide synthase in the bladder mucosa. MATERIALS AND METHODS: Six patients with interstitial cystitis and 8 controls were studied. In these 2 groups endogenous nitric oxide formation was measured and inducible nitric oxide synthase expression in bladder biopsies was analyzed at the transcriptional and protein levels by real-time polymerase chain reaction and Western blot, respectively. Immunohistochemistry for inducible nitric oxide synthase was also performed. RESULTS: Patients with interstitial cystitis had higher inducible nitric oxide synthase mRNA expression and nitric oxide formation than controls (p <0.01 and <0.001, respectively). Inducible nitric oxide synthase protein expression was up-regulated in the interstitial cystitis group. Immunohistochemistry showed that inducible nitric oxide synthase was predominantly localized to the urothelium in patients with interstitial cystitis but inducible nitric oxide synthase-like immunoreactivity was also found in macrophages in the bladder mucosa. CONCLUSIONS: The increased levels of endogenously formed nitric oxide in patients with interstitial cystitis correspond to increased inducible nitric oxide synthase mRNA expression and protein levels in these patients. Furthermore, inducible nitric oxide synthase was found to be localized to the urothelium but it was also found in macrophages in the bladder mucosa. Whether high levels of endogenously formed nitric oxide are a part of the pathogenesis in interstitial cystitis and whether it has a protective or damaging role remain to be elucidated.


Subject(s)
Biomarkers/metabolism , Cystitis, Interstitial/enzymology , Cystitis, Interstitial/pathology , Nitric Oxide Synthase Type II/metabolism , Aged , Biopsy, Needle , Blotting, Western , Cystitis, Interstitial/physiopathology , Disease Progression , Female , Gene Expression Regulation , Humans , Immunohistochemistry , Middle Aged , Nitric Oxide Synthase Type II/genetics , Prognosis , Reference Values , Reverse Transcriptase Polymerase Chain Reaction , Risk Assessment , Sensitivity and Specificity , Severity of Illness Index
8.
J Urol ; 167(1): 347-51, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11743354

ABSTRACT

PURPOSE: We examined whether the expression of angiogenic factors, such as platelet-derived endothelial cell growth factor/thymidine phosphorylase (PDEGF/TP) and transforming growth factor-beta, in bladder tissue correlates with the severity of symptoms, such as urinary urgency and bladder pain, in patients with bladder carcinoma and interstitial cystitis. MATERIALS AND METHODS: Bladder biopsy was performed in 32 patients with bladder carcinoma, including 19 with interstitial cystitis and 3 controls. Immunohistological staining for PDEGF/TP, transforming growth factor-beta and CD44 was performed in bladder specimens. PDEGF/TP in bladder tissues was also measured by enzyme-linked immunosorbent assay to examine the correlation of the expression of this factor with painful symptoms in patients with bladder carcinoma or interstitial cystitis. RESULTS: Immunohistochemical staining showed that PDEGF/TP stained in the submucosal layer beneath the basement membrane in bladder tissues of patients with interstitial cystitis and peritumoral areas of those with bladder carcinoma. In addition, PDEGF/TP, transforming growth factor-beta and CD44 stained in the same submucosal region and staining was observed at deeper submucosal levels in interstitial cystitis cases with severe rather than mild bladder pain. Quantitative analyses revealed that mean PDEGF/TP expression plus or minus standard deviation in tumor tissues of 10 patients with bladder carcinoma and pain was significantly higher than in tumor tissues of 22 with asymptomatic bladder carcinoma (129.3 +/- 70.7 versus 37.6 +/- 29.2 units per mg. protein). The mean expression of PDEGF/TP in peritumoral mucosa of patients with bladder carcinoma and pain was also significantly higher than in those with asymptomatic bladder carcinoma (75.5 +/- 42.1 versus 12.6 +/- 5.4 units per mg. protein). For interstitial cystitis mean expression in 6 patients with severe bladder pain was significantly higher than in 13 with moderate pain (79.2 +/- 59.2 versus 16.6 +/- 17.5 units per mg. protein). Mean expression in bladder tissues of controls was less than 2.3 units per mg. protein. CONCLUSIONS: These results suggest that angiogenic factors, such as PDEGF/TP and transforming growth factor-beta, may be involved in the inflammatory process to induce painful symptoms in patients with interstitial cystitis or bladder carcinoma. Proteoglycans such as CD44 may contribute to the presentation of these soluble angiogenic factors at the inflammation site.


Subject(s)
Cystitis, Interstitial/enzymology , Thymidine Phosphorylase/analysis , Urinary Bladder Neoplasms/enzymology , Aged , Aged, 80 and over , Female , Humans , Hyaluronan Receptors/analysis , Male , Middle Aged , Severity of Illness Index , Transforming Growth Factor beta/analysis , Urinary Bladder/enzymology
10.
J Urol ; 163(3): 1009-15, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10688040

ABSTRACT

PURPOSE: Interstitial cystitis (IC) is a chronic disabling condition of unknown etiology. One of its major characteristics is an increase in mast cells (MC) showing signs of activation. It has been suggested that the proteinase content defines two MC types: MC(TC), containing chymase and tryptase, and MC(T), which contains tryptase but lacks chymase. Here, we investigated the MC distribution and the MC proteinase expression in IC together with the tissue expression of the major MC growth factors, stem cell factor (SCF) and interleukin-6 (IL-6). MATERIALS AND METHODS: MC were enumerated in bladder specimens from patients with classic IC, nonulcer IC and controls. MC were visualized in terms of metachromasia, reflecting glycosaminoglycan content, and immunohistochemically, visualizing tryptase, chymase and IL-6 as well as the surface markers CD117 and SCF. RESULTS: Classic IC displayed a 6 to 10-fold increase of MC identified by proteinase content while in nonulcer IC there were twice as many MC as in controls. In contrast to nonulcer IC and controls, classic IC displayed an abundance of epithelial MC. Fewer CD117+ than proteinase+ MC were detected in IC but not in controls. Classic IC coexpressed SCF and IL-6 in the epithelium and displayed numerous SCF and IL-6+ cells in the mucosa and detrusor muscle, many of which were MC. CONCLUSIONS: Redistribution of MC into the epithelium and a high bladder wall MC density distinguish classic IC from nonulcer IC. Our findings suggest an SCF/IL-6-driven MC response in IC. They also indicate a downregulation of the SCF receptor in IC.


Subject(s)
Cystitis, Interstitial/pathology , Mast Cells/pathology , Aged , Aged, 80 and over , Cell Count , Cystitis, Interstitial/enzymology , Female , Humans , Mast Cells/enzymology , Middle Aged , Phenotype
11.
J Urol ; 159(3): 1045-8, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9474229

ABSTRACT

PURPOSE: Environmental stressors seem to play a role in exacerbation of symptoms of interstitial cystitis (IC), both in cats and in human beings. These observations suggest a role for the sympathetic nervous system in the pathophysiology of IC. To begin to assess the underlying role in IC of the pontine nucleus locus coeruleus (LC), the most important source of norepinephrine in the central nervous system, we compared the intensity of tyrosine hydroxylase immunoreactivity (THIR) in sections of LC obtained from cats with IC and from healthy cats. Cats with IC were studied during quiescent periods in an attempt to avoid the risk of flare-induced activation of the LC. MATERIALS AND METHODS: Six cats diagnosed with IC and six healthy cats were studied. Cats with IC were monitored to ensure that no behavioral or urinary signs attributable to IC had been observed for at least two weeks prior to the study. Cats were euthanized and perfused with 4% paraformaldehyde, after which brainstem tissues were collected. Coronal sections (10 microns) of LC were prepared and examined for THIR. RESULTS: THIR in total LC, parabrachial nucleus and LC complex was significantly greater (p < 0.05) in samples from cats with IC than from healthy cats. CONCLUSIONS: The increased THIR in the LC of cats with IC provides additional evidence for increased sympathetic nervous system activity in patients with IC, even during periods of absence of clinical signs.


Subject(s)
Cystitis, Interstitial/enzymology , Locus Coeruleus/enzymology , Tyrosine 3-Monooxygenase/metabolism , Animals , Cats , Cystitis, Interstitial/physiopathology , Female , Immunohistochemistry , Male , Stress, Physiological/physiopathology , Sympathetic Nervous System/physiopathology
12.
J Urol ; 158(6): 2045-50, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9366309

ABSTRACT

PURPOSE: We attempted to determine whether oral L-arginine, the substrate for nitric oxide synthase, increases nitric oxide synthase activity and cyclic guanosine monophosphate (cGMP) levels in the urine from interstitial cystitis patients. Nitric oxide and cGMP are decreased in urine from interstitial cystitis patients and both induce smooth muscle relaxation and immunological responses. Increasing urinary nitric oxide and cGMP may ameliorate interstitial cystitis symptoms. MATERIALS AND METHODS: Eight patients with interstitial cystitis were given L-arginine (1,500 mg. a day) orally for 6 months. Before and during treatment nitric oxide synthase activity and inducible nitric oxide synthase protein, cGMP, nitrate plus nitrite and interleukin 8 (IL-8) levels were measured in urine. RESULTS: After 2 weeks to 1 month of oral L-arginine treatment, urinary levels of nitric oxide synthase related enzymes and products increased significantly, while levels of the cytokine IL-8 were not changed significantly. IL-8 was significantly elevated in interstitial cystitis patients with leukocyte esterase positive urine. CONCLUSIONS: Long-term oral administration of L-arginine increases nitric oxide related enzymes and metabolites in the urine of patients with interstitial cystitis, which is associated with a decrease in interstitial cystitis related symptoms.


Subject(s)
Arginine/administration & dosage , Cystitis, Interstitial/enzymology , Cystitis, Interstitial/urine , Nitric Oxide Synthase/metabolism , Administration, Oral , Cyclic GMP/metabolism , Female , Humans , Nitrates/metabolism , Nitrites/metabolism , Time Factors
13.
J Urol ; 158(3 Pt 1): 993, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9258128
SELECTION OF CITATIONS
SEARCH DETAIL
...